Clinical Trial Update: Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating 123I IMPY with SPECT imaging to detect beta-amyloid in the brain for Alzheimer's disease has been completed. The study investi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 123I IMPY (IMPY)

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED